You can buy or sell Ocugen, Inc and other stocks, options, ETFs, and crypto commission-free!
Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline of therapies includes OCU400, OCU410, OCU200, OCU100, and OCU300. Read More The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA.
52 Week High
52 Week Low
— per share
$0.89 per share